Bertha Coombs
Showing 1–3 of 3 transcripts.
- Milken Institute1h 23m
Leading the Next Era of Health | Future of Health Summit 2025
Bertha Coombs, Joe Daly, Jeremy David, Shane Jacobson, Sarah London, Baligh Yehia, Esther Krofa
Hosted by the Milken Institute in Washington, the 2025 Future of Health Summit convened over 200 speakers to address urgent systemic challenges including rising costs, stagnant life expectancy, and a 10-point decline in public trust. The event highlighted critical interventions such as Dr. Jill Biden's new Women's Health Network, Centene's food-as-medicine data initiatives, and Jefferson Health's AI-driven physician support programs, while launching nine strategic publications on biomedical research. Key participants navigated complex tensions regarding AI's role in workflows, the need for new financing models for expensive therapies, and the precarious status of Affordable Care Act tax credits, ultimately urging leaders to leverage micro-level patient-clinician trust for future reform.
- Milken Institute29 min
The Next Era of Women’s Health | Future of Health Summit 2025
Bertha Coombs, Jill Biden, Lupita Nyong'o, John Whyte
Federal initiatives led by First Lady Jill Biden have allocated $1 billion to address historical sex-based biases in medical research following decades of excluding women from clinical trials. This funding, supported by high-profile advocates like Lupita Nyong'o, aims to prioritize critical issues such as uterine fibroids and cardiovascular disease while pushing for legislative changes that reclassify necessary treatments as medically essential rather than elective. Despite these strides, systemic challenges remain, including the need to correct male-centric data in artificial intelligence and shift medical culture toward holistic, patient-centered dialogue to ensure equitable care outcomes.
- Milken Institute20 min
A Conversation with CMS Director of Medicare Meena Seshamani | Future of Health Summit 2024
Meena Seshamani, Bertha Coombs
A multidisciplinary team comprising experts from drug pricing, pharmacy, and economics has implemented health care reforms focused on treating developmental issues, chronic illnesses, and behavioral health within the Medicare and Medicaid systems. These initiatives, which include updating risk adjustment methodologies and navigating the Inflation Reduction Act, aim to reduce prescription drug costs for seniors and integrate services to address over 400,000 additional conditions. With a target deadline of September 1st for international financial agreements, the organization plans to execute these changes over five to eight months while utilizing new communication platforms and patient feedback to ensure system stability.